MedPath

Impact of Real-time Notification of Colonoscopic Optical Diagnosis on Patients' Anxiety and Depression After Polypectomy

Not Applicable
Recruiting
Conditions
Colorectal Neoplasms
Colonic Polyp
Colonoscopy
Anxiety
Depression
Interventions
Other: Real-time endoscopic optical diagnosis
Registration Number
NCT05517343
Lead Sponsor
Fu Jen Catholic University
Brief Summary

The accuracy of endoscopic optical diagnosis for colorectal polyps has been approaching histological diagnosis after implementation of image enhancement endoscopic technologies. The real-time notification of possible nature of resected polyp after colonoscopy is expected to reduce the anxiety and depression level of the patients before the availability of histological diagnosis and improve their quality of life. We designed and conducted a randomized control trial to confirm this hypothesis.

Detailed Description

This is a single center, open-label, prospective and parallel randomized controlled trial. This study planning to recruit outpatients from the age of 40 to 79 who are scheduled to undergo sedated colonoscopy. Once eligible subjects were diagnosed of colorectal polyps during colonoscopy and received polypectomy, they will be randomized into "ordinary care group (explained at next scheduled clinic)" and "real-time notification group (explained immediately after colonoscopy)". The level of anxiety, depression of the two groups will be measured by using the Taiwan version questionnaire of Hospital Anxiety and Depression Scale (HADS) right before the next scheduled clinic for histological results and compared the difference between the two groups.This study is expected to determine the impact of real-time notification of colonoscopic optical diagnosis on patients' anxiety and depression after polypectomy, and provide evidence to improve post-polypectomy care.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Age of ≥ 40 years and < 80 years
  • Outpatients who prepare receiving sedated colonoscopy
  • Subjects who have signed informed consent form of this study
  • Informed consensus has been obtained that endoscopic resection should be performed if a colorectal polyp is found
  • Eastern Cooperative Oncology Group (ECOG) performance status scale among 0 to 2
Exclusion Criteria
  • Subjects with any of the following prior history or current conditions:
  • (a) Contraindications to colonoscopy
  • (b) Major mental illnesses, e.g. major depressive disorder, schizophrenia, generalized anxiety disorder ...
  • (c) Inflammatory bowel disease
  • (d) Hereditary or non-hereditary polyposis syndrome, hereditary non-polyposis colorectal cancer
  • (e) Uncured colorectal cancer
  • (f) Active gastrointestinal bleeding
  • (g) Pregnancy
  • Subjects who do not received polypectomy during colonoscopy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Real-time notification (RTN)Real-time endoscopic optical diagnosisThe participants of this arm received the endoscopic optical diagnosis of the resected colon polyps and the recommended surveillance colonoscopy schedule right after the sedated colonoscopy. Histological diagnosis will be informed at next scheduled clinic visit (around 1 to 2 weeks later).
Primary Outcome Measures
NameTimeMethod
Proportion of definite anxiety casesThis outcome will be assessed right before the next scheduled clinic for histological results (around 1 to 2 weeks after polypectomy)..

The level of anxiety of the two study arms will be measured by using the Taiwan version questionnaire of Hospital Anxiety and Depression Scale (HADS) right before the next scheduled clinic for histological results. The anxiety score of this questionnaire ranging from 0 to 21. Scored 0 to 7 defined as normal case, scored 8 to 10 defined as doubtful case, and scored 11 to 21 defined as definite case. The proportion of definite anxiety cases of the two study arms will be compared.

Proportion of definite depression casesThis outcome will be assessed right before the next scheduled clinic for histological results (around 1 to 2 weeks after polypectomy)..

The level of depression of the two study arms will be measured by using the Taiwan version questionnaire of Hospital Anxiety and Depression Scale (HADS) right before the next scheduled clinic for histological results. The depression score of this questionnaire ranging from 0 to 21. Scored 0 to 7 defined as normal case, scored 8 to 10 defined as doubtful case, and scored 11 to 21 defined as definite case. The proportion of definite depression cases of the two study arms will be compared.

Secondary Outcome Measures
NameTimeMethod
Anxiety scoreThis outcome will be assessed right before the next scheduled clinic for histological results (around 1 to 2 weeks after polypectomy)..

The level of anxiety of the two study arms will be measured by using the Taiwan version questionnaire of Hospital Anxiety and Depression Scale (HADS) right before the next scheduled clinic for histological results and compared the difference between the two study arms. The anxiety score of this questionnaire ranging from 0 to 21. Higher score means higher anxiety level.

Depression scoreThis outcome will be assessed right before the next scheduled clinic for histological results (around 1 to 2 weeks after polypectomy)..

The level of depression of the two study arms will be measured by using the Taiwan version questionnaire of Hospital Anxiety and Depression Scale (HADS) right before the next scheduled clinic for histological results and compared the difference between the two study arms. The depression score of this questionnaire ranging from 0 to 21. Higher score means higher depression level.

Trial Locations

Locations (1)

Fu Jen Catholic University Hospital

🇨🇳

New Taipei City, Taiwan

© Copyright 2025. All Rights Reserved by MedPath